New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 22, 2013
10:20 EDTABBV, SKX, BRD, USG, AEM, NFLX, LBAI, AAPL, VFC, VMI, PRGO, MIG, BHP, BZH, CIR, EQIX, EADSY, FHN, HES, JCI, MDC, HXLOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AbbVie (ABBV) upgraded to Overweight from Equal Weight at Morgan Stanley... BHP Billiton (BHP) upgraded to Overweight from Neutral at HSBC... Beazer Homes (BZH) upgraded to Outperform from Neutral at Credit Suisse... CIRCOR (CIR) upgraded to Buy from Hold at BB&T... EADS (EADSY) upgraded to Outperform from Sector Perform at RBC Capital... Equinix (EQIX) upgraded to Overweight from Equal Weight at Stephens... First Horizon (FHN) upgraded to Neutral from Sell at Compass Point... Hess Corp. (HES) upgraded to Overweight from Equal Weight at Barclays... Johnson Controls (JCI) upgraded to Outperform from Neutral at RW Baird... M.D.C. Holdings (MDC) upgraded to Neutral from Underperform at Credit Suisse... Meadowbrook Insurance (MIG) upgraded to Outperform at Keefe Bruyette... Perrigo (PRGO) upgraded to Overweight from Neutral at JPMorgan... Skechers (SKX) upgraded to Buy from Hold at BB&T... USG (USG) upgraded to Neutral from Underperform at Credit Suisse... Brigus Gold (BRD) upgraded to Buy from Neutral at Global Hunter... Agnico-Eagle (AEM) upgraded to Buy from Neutral at Global Hunter... Netflix (NFLX) upgraded to Neutral from Sell at B. Riley... Apple (AAPL) upgraded to Buy from Hold at BGC Partners... Lakeland Bancorp (LBAI) upgraded to Outperform from Neutral at Macquarie... VF Corp. (VFC) upgraded to Outperform from Neutral at Wedbush... Valmont (VMI) upgraded to Outperform from Neutral at Wedbush... Hexcel (HXL) upgraded to Outperform from Sector Perform at RBC Capital.
News For ABBV;BHP;BZH;CIR;EQIX;EADSY;FHN;HES;JCI;MDC;MIG;PRGO;SKX;BRD;USG;AEM;NFLX;LBAI;AAPL;VFC;VMI;HXL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | all recent news | >>
October 16, 2014
08:52 EDTABBVAbbVie price target lowered to $59 from $71 at BMO Capital
Subscribe for More Information
08:06 EDTAAPLAlmunia says political pressure around Google case 'unprecented,' WSJ reports
Subscribe for More Information
07:58 EDTNFLXNetflix weakness a buying opportunity, says RW Baird
Subscribe for More Information
07:48 EDTAAPLSony must decide quickly what to do with smartphone strategy, Nikkei says
Sony's (SNE) "One Sony" strategy is built around providing contents to consumers and smartphones are one of three pillars it sees for growth, but the strategy is "on the brink of collapse" as the company falls behind Apple (AAPL) and Chinese rivals, according to the Nikkei Asian Review. Sony officials are debating whether smartphone operations in Asia should be downsized and whether cutting 1,000 jobs, or 15% of its mobile communications workforce, would be warranted, according to the report. Reference Link
07:23 EDTNFLXFutures suggest market plunge
Subscribe for More Information
07:23 EDTBHPHart Energy to hold a conference
Subscribe for More Information
07:19 EDTNFLXNetflix new content can 'reinvigorate' growth, says JPMorgan
Subscribe for More Information
07:16 EDTNFLXNetflix shares should be bought on weakness, says RBC Capital
Subscribe for More Information
07:04 EDTNFLXNetflix price target lowered to $415 from $500 at Cantor
Cantor cut its price target on Netflix after the company reported lower than expected Q3 subscriber growth and provided lower than expected Q4 subscriber guidance. However, the firm keeps a Buy rating on the shares, citing the ongoing shift to Internet TV and Netflix's strong position in that segment.
06:53 EDTBHPBHP Billiton to pursue U.K. listing for new company to be created via demerger
Subscribe for More Information
06:53 EDTEADSYAirbus head says defense companies unwelcome in Germany, Reuters says
In a report from German newspaper Handelsblatt, Airbus CEO Tom Enders said that Germany should not be astounded if more defense firms feel unwanted in the country since he believes that the industry is treated unfairly there, according to Reuters, citing comments from Enders. Reference Link
06:47 EDTEADSYAirbus head mulls basing new helicopter programs in France, Reuters says
After Germany hindered the export of military helicopters to Uzbekistan, Airbus CEO Tom Enders said that the airplane maker was seriously contemplating if it should establish its new helicopter programs in France instead of Germany in the future, according to Reuters, citing comments from Enders. Reference Link
06:39 EDTNFLXNetflix October volatility elevated into disappointing Q3
Subscribe for More Information
06:26 EDTNFLXNetflix price target lowered to $364 from $453 at Citigroup
Subscribe for More Information
06:20 EDTNFLXNetflix downgraded to Fair Value from Buy at CRT Capital
CRT Capital downgraded Netflix to Fair Value and reduced its price target to $375 from $510 following disappointing Q3 results. The analyst said Netflix invests heavily in content and expansion, faces increasing competition, and lack s enough near-term catalysts to move shares.
06:17 EDTABBVJefferies says Medtronic 'needs to do' Covidien takeover
Jefferies says it "can't see how Medtronic walks" from the Covidien (COV) takeover given how compelling the merger is. The firm confirmed with Medtronic (MDT) that nothing has changed in the company's commitment to the deal since new financing terms were announced on October 3. In Jefferies view, "Medtronic needs to do this deal." It notes the spread on the acquisition widened significantly on the news that Abbvie (ABBV) is reconsidering its acquisition of Shire (SHPG).
06:00 EDTNFLXNetflix upgraded to Hold from Underperform at Jefferies
Jefferies upgraded Netflix to Hold with a $300 price target citing a more favorable risk/reward following the post-earnings sell-off.
05:52 EDTNFLXNetflix price target lowered to $345 from $434 at Piper Jaffray
Subscribe for More Information
05:37 EDTABBVShire releases statement regarding AbbVie withdrawal of recommendation
Subscribe for More Information
05:21 EDTABBVAbbVie recommends holders vote against Shire transaction
Following Shire's (SHPG) waiver of the three-day notice period, AbbVie (ABBV) announces its board withdraws its recommendation made on July 18 regarding the proposed Shire transaction and recommends that stockholders vote against the transaction. AbbVie and its board made this determination following a detailed consideration of the impact of the U.S. Department of Treasury's unilateral changes to the tax rules, as issued on September 22. The breadth and scope of the changes, including the unexpected nature of the exercise of administrative authority to impact longstanding tax principles, and to target specifically a subset of companies that would be treated differently than either other inverted companies or foreign domiciled entities, introduced an unacceptable level of uncertainty to the transaction. Additionally, the changes eliminated certain of the financial benefits of the transaction, most notably the ability to access current and future global cash flows in a tax efficient manner as originally contemplated in the transaction. This fundamentally changed the implied value of Shire to AbbVie in a significant manner. Under the conditions of AbbVie's offer and the terms of the Co-operation Agreement, the withdrawal of the recommendation alone will not cause a lapse of AbbVie's offer or terminate the Co-operation Agreement between AbbVie and Shire. Unless Shire and the U.K. Takeover Panel agree otherwise, AbbVie must convene an AbbVie stockholder meeting to consider the adoption of the U.S. merger agreement. AbbVie's offer will lapse if the company's stockholders do not adopt the agreement. Assuming Shire provides the requisite cooperation and consents, a pre-effective amendment to the registration statement filed by AbbVie Private Limited in connection with the combination is expected to be filed with the SEC as soon as practicable. Under the terms of the Co-operation Agreement, following the withdrawal of the AbbVie Board of Directors' recommendation, a break fee of approximately $1.64B will be payable to Shire if either: AbbVie stockholders do not approve the adoption of the U.S. merger agreement at an AbbVie stockholder meeting; or such a meeting does not occur by December 14.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use